Myosin VI (M6) is a class of unconventional myosins that translocates along actin filaments to move and localize components within eukaryotic cells. Dimeric M6 undergoes processive motion, with a single molecule taking large, \~36-nm steps along an actin filament and traveling hundreds of nanometers without dissociation[@R1]-[@R3]. M6 is unique in the myosin superfamily as it moves to the (--) end of actin filaments[@R4], as a result of the addition of a unique insert of \~40 residues that forms a hairpin turn inserted in its lever arm just as it exits the catalytic head at the converter domain[@R5]-[@R7].

The processive step of M6 (refs. [@R1]-[@R3],[@R8]-[@R11]) is similar in size to that of myosin V[@R12]-[@R14], even though its lever arm is composed of only two calmodulin light chains[@R15], three times fewer than the six light chains of myosin V. It was therefore unclear whether M6 could work by the lever arm hypothesis[@R16] given the apparent lack of reach. This dilemma was partially resolved when it was shown that the M6 lever arm swings through \~180°[@R6], compared to only \~70° for myosins II and V[@R17],[@R18], thus allowing for a large stroke size despite its short lever arm. This \~180° swing requires an unexpected change in the conformation of the converter, and the movement of the end of the IQ domain should be \~12 nm[@R19]. How the M6 reaches the additional \~24 nm to achieve a stride of \~36 nm remains to be understood. One possibility is the presence of a flexible element located C-terminal to the lever arm, presumably just proximal to it, which allows the free head to diffuse forward the additional \~24 nm. This flexibility was suggested to be in the \~70-residue region just proximal to the lever arm, possibly configured as a random coil, with the next \~70 residues or medial tail region forming a coiled coil for dimerization[@R8],[@R20]. Here we show that the proximal tail is actually structured, and the medial tail does not dimerize but provides the additional needed reach as a single α-helix, as was suggested by previous work that revealed an analogous structure in the tail of myosin X[@R21].

Whereas full-length M6 is monomeric[@R22], recent studies indicate that M6 loaded onto vesicles is dimeric[@R23],[@R24] and that increasing the effective concentration of M6 leads to dimerization[@R25], showing that dimerization is possible. With the determination that the medial tail does not act as a dimerization domain, the assembly of M6 dimers became perplexing. Here we demonstrate that the cargo binding domain dimerizes the tail, but only in the absence of the M6 head. Additionally, the monomeric full-length protein has the cargo binding domain folded back onto the head, potentially in a regulated state that inhibits dimerization. This is consistent with previous results showing that full-length chicken M6 is monomeric and compact[@R22].

RESULTS {#S}
=======

The M6 tail is composed of four distinct domains {#S2}
------------------------------------------------

The sequence of the \~450 residues immediately following the catalytic head and the known lever arm of M6 can be divided into four regions ([Fig. 1](#F1){ref-type="fig"} and [Supplementary Fig. 1](#SD2){ref-type="supplementary-material"} online). The characteristic heptad repeat pattern of a coiled coil with hydrophobic residues dominating the *a* and *d* positions is identifiable only in the first \~70 residues, which we call the proximal tail (PT, Pro835--Glu907; numbering is based on the human sequence). A transition to the second domain, also \~70 residues, occurs somewhere between Glu907 and Gln915. After Gln915, an extended run of alternating charge appears with only a few hydrophobic residues, the medial tail (MT, Glu908--Arg980) ([Fig. 1](#F1){ref-type="fig"}). This alternating-charge pattern abruptly ends at residue Arg980, and the C-terminal tail sequence of \~50 residues just before the cargo binding domain has no obvious primary-sequence motifs; we call this region the distal tail (DT, Ile981--Arg1035). We refer to the fourth and final region of \~250 residues as the cargo binding domain (CBD, Arg1036--Lys1285).

The PT is a folded domain required for long steps {#S3}
-------------------------------------------------

The PT has been proposed to be a random coil acting as the flexible element in the M6 tail that spans the remaining \~24-nm gap[@R20]. To explore this model, we created three M6 mutants with altered PT domains ([Supplementary Fig. 2a](#SD2){ref-type="supplementary-material"} online). The three constructs changed the sequence to varying degrees ranging from point mutations that removed nine core hydrophobic residues, proposed to be *a* and *d* positions on the basis of coiled-coil prediction algorithms[@R26] (altered A&D), to randomization of up to 58 residues (850--907 random and 857--907 random). These changes were not expected to impair function if the proximal tail is a random coil, and hence these mutants would be expected to show the same stepping behavior of the control M6 dimer[@R1]; however, they would be expected to disrupt any organized tertiary structure. By labeling the motors with fluorophores, the motion of single molecules along actin filaments on the surface can be observed in a total internal reflection fluorescence (TIRF) microscope, allowing the rate of motion to be determined. Each of the three mutant constructs showed velocities in TIRF motility assays at 80 μM ATP that were only \~50% of that of the control M6 dimer ([Supplementary Fig. 2b,c](#SD2){ref-type="supplementary-material"}). Because velocities can be altered by changing either step size or the rate of stepping, detailed optical trap assays were undertaken for one of the mutants. In this case, two beads are attached to an actin filament, one at each end, and held in two separate optical traps. The filament is then positioned above a single motor on the surface, and individual interactions between the motor and the filament are observed. Processive motors produce a characteristic staircase pattern where the displacement between plateaus measures the step size and the duration of the dwell measures the rate of stepping. These assays showed that the altered velocities result from a shortened step size and not altered stepping rates ([Supplementary Fig. 2d,e](#SD2){ref-type="supplementary-material"}). Therefore, the model of the PT as a random coil is unlikely.

CD spectroscopy was used to determine what secondary-structure elements were present in the PT. CD revealed that the PT has a classic α-helical spectrum with minima at 222 nm and 208 nm and a maximum at 194 nm ([Fig. 2a](#F2){ref-type="fig"}). We estimated that \~80% of the residues in the PT are in an α-helical conformation. The strong minimum at 222 nm was measured as a function of temperature to track the stability of the PT. It unfolds in a cooperative manner characteristic of compact proteins, where tertiary contacts stabilize the secondary structure ([Fig. 2a](#F2){ref-type="fig"}). These results indicate that the PT is a compact domain with a defined structure. This conclusion agrees with the hydrodynamic radius determination from gel filtration, which is that predicted for a spherical compact protein[@R27] ([Table 1](#T1){ref-type="table"}). An estimate of the PT structure (residues 835--915, in the human sequence) from the Rosetta 2.2.0 structure prediction algorithm[@R28] consistently yielded (7 out of 10 runs) a three-helix bundle with an end-to-end distance of \~3 nm, which is in good agreement with all experimental data and is considered to be a good estimate of the PT structure ([Supplementary Fig. 3a,b](#SD2){ref-type="supplementary-material"} online).

The MT is a single α-helix providing reach for 36-nm steps {#S4}
----------------------------------------------------------

Two previous models have been put forward for the MTof M6. First, it has been suggested that at high concentrations M6 dimerizes via coiled-coil formation[@R25]. Second, M6 contains a charge-repeat pattern homologous to a domain in myosin X that has been shown to be a single α-helix in solution[@R21], suggesting that M6 may take the same conformation. To test these models, the MT and DT domains were expressed together in *Escherichia coli* and purified to homogeneity. A clear difference between the two models is that the coiled coil would be dimeric and the single α-helix would be monomeric. Multiple-angle light scattering (MALS) is capable of determining molecular weights in solution by measuring scattering as a function of angle while simultaneously measuring the protein concentration. Using MALS, we found that the MT-DT is monomeric, consistent with the single α-helix hypothesis. This was corroborated by dynamic light scattering, which measures light scattering as a function of time to determine the hydrodynamic radii (*R*~h~). The measured *R*~h~ of 3.6 nm is consistent with an extended structure rather than a globular one (1.8 nm predicted[@R27]; [Table 1](#T1){ref-type="table"}). Furthermore, the CD spectrum and thermal melt curves of the MT-DT are those expected of a single α-helix, with a strongly α-helical spectrum and a broad thermal unfolding transition spanning \~70 °C, as shown for charged synthetic peptides[@R29] ([Fig. 2b](#F2){ref-type="fig"}). To directly assess the global structure of the domains, we recorded small-angle X-ray scattering (SAXS) profiles and used *ab initio* reconstructions to develop low-resolution structural models of the MT-DT construct. The reconstruction for MT-DT ([Fig. 3a](#F3){ref-type="fig"}), as well as that for the PT-DT construct ([Fig. 3b](#F3){ref-type="fig"}), shows a long, bent, slender cylinder, similar in length to that expected with the 70-residue MT configured as a single α-helix.

Although the MT-DT is monomeric under these conditions, it is possible that it was not assayed at a high enough concentration to dimerize. To increase the effective concentration, a Gly-Gly-Cys sequence was placed at the C terminus of the natively cysteine-free MT-DT construct, so that two copies could be held in close proximity by a specific disulfide bridge. This mechanism, which has been used in the study of the GCN4 coiled coil[@R30], does not inhibit coiled-coil formation and results in an apparent concentration of at least 4 mM[@R31]. The CD spectrum and melt profile of this oxidized dimer were essentially identical to that of the MT-DT monomer ([Fig. 2b](#F2){ref-type="fig"}), showing that even under these conditions the MT-DT is unable to form a dimeric coiled coil.

Constraining the MT eliminates processive stepping {#S5}
--------------------------------------------------

The above results are consistent with the MT providing the reach needed for the 36-nm step of M6. If the MT-DT domain is the long element that allows the two heads of M6 to separate during processive stepping, removing that reach will alter that processive stepping. A GCN4 sequence was placed just beyond the PT-MT boundary at residue 920 ([Fig. 1](#F1){ref-type="fig"}, MT locked). This locks the two copies of M6 together in a coiled coil at this position and eliminates any contribution of the MT to processive stepping. The impact on motion was tested in gliding filament assays, where fluorescently labeled actin filaments glide across a motor-covered surface. This geometry is useful as it can assay both processive and nonprocessive motors, whereas the TIRF motility assay can assay only processive motors. Control M6 dimer at 2 mM ATP moved at 110 ± 21 nm s^−1^, and MT locked moved at 75 ± 26 nm s^−1^, significantly different results as assessed by a *t*-test (*n* = 20 per group, *P*-value \> 0.001). The 75 nm s^−1^ velocity is that expected for a stroke size of \~20 nm, which derives from the \~180° swing of the lever arm extended by the globular PT.

Gliding filament assays are capable of testing more than just the velocity of a motor. Other parameters, such as the rate at which filaments land on the surface and the fraction of filaments that move greater than their length, can also be counted. The theoretical framework of the landing and continuous movement assays allows for quantitative predictions of the landing rate and the fraction of filaments that will move greater than their length as a function of motor density and the number of motors it takes to attach a filament to the surface[@R32]. We created models in which either one motor (processive movement) or two motors (nonprocessive movement) were needed for filament attachment. Data from the control M6 dimer were more consistent with the processive model, whereas the MT locked construct was more consistent with the nonprocessive model in both assays ([Fig. 4a,b](#F4){ref-type="fig"}). Optical trap assays also indicate that a single motor of MT locked is incapable of producing the characteristic staircases of a processive motor. Instead, single bind-and-release events, characteristic of nonprocessive motors, were seen with a mean displacement of 23 ± 26 nm ([Fig. 4c](#F4){ref-type="fig"}) and kinetics similar to the control M6 dimer with a mean dwell of 0.9 ± 0.02 s. From these data, we conclude that the MT is the primary element in M6 that allows the heads to sample a large space and processively step along the 36-nm pseudorepeat of the actin filament.

The CBD regulates dimerization of M6 {#S6}
------------------------------------

Neither the PT nor the MT dimerize at \~1 μM ([Table 1](#T1){ref-type="table"}). To further explore M6 dimerization, we examined the role of the CBD. Indeed, MALS analysis showed that a construct extending from the beginning of the PT to the end of the CBD is dimeric at concentrations in the micromolar range, which indicates reasonable affinity ([Table 1](#T1){ref-type="table"}). Because the PT and the MT-DT do not self associate at these concentrations, we conclude that the CBD is needed for this dimerization. However, under the same conditions, the full-length M6 is monomeric ([Table 1](#T1){ref-type="table"}), in agreement with previous work[@R22]. From these results, we conclude that the CBD dimerization must be inhibited by the M6 head. This is corroborated by the compactness of the SAXS envelope of full-length M6 ([Fig. 5](#F5){ref-type="fig"}). If the model for the PT-MT ([Fig. 3b](#F3){ref-type="fig"}) is fused to the structure of the M6 head and a globular CBD, the resultant full-length M6 monomer cannot fit into the experimental SAXS envelope without a high degree of bending ([Fig. 5](#F5){ref-type="fig"}). This implies that the full-length M6 monomer is in a folded-back state, with an interaction occurring between the CBD and the M6 head, and that this interaction inhibits dimerization. It is likely that the binding of cargo to the CBD helps regulate the equilibrium between this folded-back monomeric state and the dimeric form of M6, especially given the orientation of the CBD when bound to the membrane[@R23] and the observation that M6 dimerizes when binding to membrane[@R24].

DISCUSSION {#S7}
==========

The average spacing between the two heads of the processively stepping M6 dimer is 36 nm, yet the lever arm structure that encompasses the two calmodulin binding domains swinging through an angle of \~180° explains the protein structure for only \~12 nm of this distance[@R19]. This leaves a large 24-nm gap that needs to be spanned by relatively few residues. One possibility is that this gap is filled by both the PT and the MT, and the CBD self-associates to hold the two copies of the full-length M6 together. Because PT is a globular folded domain that immediately follows the calmodulin binding domains, the PT could extend the lever arm by as much as \~3 nm. Owing to the \~180° lever arm rotation, this \~3-nm extension would increase the stroke size of the motor by \~6 nm to a total of 18 nm[@R6]. This would leave an \~18-nm gap in the stride distance of the two heads of the stepping dimer that must be filled by the MT-DT. The MT, owing to its stable single α-helix, is \~10 nm long, with the DT adding an additional \~3 nm, assuming a somewhat folded DT structure ([Fig. 3a](#F3){ref-type="fig"}). Thus, two copies of MT-DT are more than sufficient to bridge the gap between the two heads and would also allow step sizes larger than 36 nm, as has been reported[@R1]-[@R3] ([Fig. 6](#F6){ref-type="fig"}). This model is supported by the linear arrangement of the PT-MT-DT domains suggested by the SAXS envelope ([Fig. 3b](#F3){ref-type="fig"}), where the IQ-based lever arm is simply being extended by an additional rod-like segment.

It should be emphasized that the angle between the folded PT and the canonical calmodulin-IQ lever arm is unknown, and the PT may be orientated such that it does not add its full-length to the working stroke of the motor. In fact, it is even possible that the PT may actually shorten the stroke if it is able to fold back onto the IQ-bound calmodulin, in an arrangement made possible because the MT is long enough to bridge the gap between the heads without help from the PT. This model of the PT folding back onto the IQ-calmodulin lever arm actually leads to a better fit into the monomeric full-length SAXS envelope ([Fig. 5](#F5){ref-type="fig"}). This raises the possibility that the purpose of the PT may not be to extend the lever arm, but rather to mediate interactions with other proteins. This fits with the observation that the *Drosophila melanogaster* protein Echinoid was identified as binding M6 at the PT[@R33]. It is also possible that the PT is part of the binding site for the M6 CBD in the folded-back structure in [Figure 5](#F5){ref-type="fig"}. The role of the PT is most likely to be some hybrid of the two orientations described, emphasizing the need for additional structural studies to completely characterize the IQ and PT junction and the role of the PT.

The \~10-nm single α-helical structure of the MT is remarkable, with few other natural examples[@R21],[@R34],[@R35] in known protein structures. The characteristic i to i+4 alternating-charge pattern ([Fig. 3b](#F3){ref-type="fig"}, inset) has been shown previously to stabilize α-helical peptides in solution[@R34]; it has also been noted that the MT is similar to the single stable α-helix that has been described for myosin X and is proposed to extend the myosin X lever arm[@R21]. Studies on the material properties of other single α-helices indicate that the Young's modulus for lateral bending is \~2.5 GPa[@R36],[@R37], which would lead to a persistence length of \~12 nm. This suggests that the MT would not be a rigid rod at the scale of these lengths, which is supported by the observation that synthetic α-helical peptides have radii of gyration shorter than expected for rigid rods[@R38]. This seems contradictory with the MT adding to the stroke of M6, but the previously studied peptides have only one stabilizing i to i+4 interaction per helical turn, whereas the MT has as many as four of these interactions, potentially enhancing its rigidity and enabling it to extend the lever arm. A rigid MT is supported by the *R*~h~ measurement of 4.3 nm, which is in agreement with the predicted 3.7-nm radius of gyration from the suggested structure, indicating that the static model has similar properties to the dynamic object in solution. The hypothesis of the rigid tail domain is made more plausible with the recent observations that the M6 head can adopt many lever angles that could explain the highly variable step size of M6 (refs. [@R19],[@R39]), without requiring a flexible tail domain. Further experimentation is needed to clarify the material properties of the MT and its exact contribution to the M6 stroke.

With the PT and MT spanning the distance between the two heads, the CBD does not need to add to the reach of the M6 dimer. Here we show that at \~1 μM the PT-DT is monomeric, whereas the CBD can initiate dimerization of the tail. Notably, it was previously reported that, when the effective M6 concentration is increased using monoclonal antibody binding to the C terminus or rigor binding of M6 monomers to F-actin, a construct ending at residue 992 in the DT seems to dimerize, as judged by rotary-shadowing EM and single-molecule processive movement[@R25]. Remarkably, this dimerization persists under dilute conditions (less than nanomolar concentrations) used in single-molecule assays. Further experiments are necessary to explain the persistent dimerization observed in their construct, given that our studies show that PT-DT does not dimerize at 1 μM. However, our experiments suggest that the CBD is the preferred dimerization interface for the M6 helical tail, as depicted in our model ([Fig. 6](#F6){ref-type="fig"}).

We find that the full-length M6 structure is compact, resulting from a folding back of the CBD onto the M6 head. It has recently been observed that a high degree of flexibility exists in the M6 motor domain[@R7],[@R19],[@R39]. This flexibility exists before the beginning of the lever arm and presumably relates to the ability of the lever arm to adopt multiple angles relative to the head. This variability in the lever arm angle could influence the folded-back state that we observe, but it is clear that a separate new flexibility is needed to create the folded-back state proposed here. It is unclear from where this new flexibility originates, given that all of the tail fragments seem rigid. One possibility is that the joints between the domains are flexible, enabling the domains to bend with respect to each other. Another possibility is that the energy released upon CBD docking to another part of the structure may be enough to induce a change in one of the tail domains, creating a bend. Thus, there could be two possible IQ-PT connection angles: one in the monomeric folded state ([Fig. 5](#F5){ref-type="fig"}) and another in the extended dimeric state ([Fig. 6](#F6){ref-type="fig"}). Alternatively, the MT might rearrange as there are several places where the repeating-charge pattern is less robust and the MT is presumably more likely to bend.

We propose a model for M6 regulation where the cytoplasmic CBD dimerization is inhibited by binding of the CBD to the M6 head, and upon binding to cargo the CBD releases the head and initiates dimerization. This allows us to draw a scale model of stepping M6 ([Fig. 6](#F6){ref-type="fig"}) that successfully accounts for the behavior of the motor and assigns the necessary functions to each domain.

METHODS {#S8}
=======

Expression of tail domain constructs {#S9}
------------------------------------

Further details for all of the methods are included in the [Supplementary Methods](#SD2){ref-type="supplementary-material"} online. The temperature was 22 °C, unless otherwise noted. The appropriate sequences from the human M6 cDNA were cloned into a modified pET28a vector (EMD Chemicals). The modified vector contained a hexahistidine (His~6~) tag, maltose binding protein (MBP) and a tobacco etch virus (TEV) protease cleavage site 5′ to the cloning site. Proteins were expressed in *E. coli* Rosetta (DE3) cells (EMD Chemicals) at room temperature, with all subsequent purification steps being conducted at 4 °C. Cells were lysed by sonication. Lysates were clarified by centrifugation at 100,000*g* for 30 min and bound to nickel--nitrilotriacetic acid (Ni-NTA) resin (Qiagen). The eluted proteins were dialyzed in the presence of TEV protease (1:100 by weight) overnight to cleave the His~6~ and MBP portions from the M6 domains. M6 domains were further purified by running the cleavage reaction over a Ni-NTA column to remove His~6~-containing fragments, running a MonoQ column (GE Healthcare) and running a Superdex 200 column (GE Healthcare) in either CD buffer (10 mM phosphate, pH 7.4, 25 mM NaCl) or scattering buffer (10 mM phosphate, pH 7.4, 150 mM NaCl).

Expression of motor domain--containing constructs {#S10}
-------------------------------------------------

The porcine control M6 dimer construct described previously[@R40] was modified to create the mutants, and full-length M6 was made using the human M6 cDNA. M6 altered A&D, 850--907 random, and 857--907 random sequences were synthesized by DNA 2.0 (Menlo Park). The altered protein sequences are described in [Supplementary Figure 2](#SD2){ref-type="supplementary-material"}. M6 MT locked was made with a GCN4 sequence inserted in place of residues 919--950 of the control dimer. All sequences were placed under the control of the polyhedron promoter of the pFastBac Dual vector (Invitrogen), with sea urchin calmodulin (P05934) under the control of the p10 promoter. Recombinant baculoviruses were created as per the Invitrogen protocol. Proteins were purified as described previously[@R40]. Briefly, Sf-9 cells were infected with recombinant virus at 28 °C, with all subsequent purification steps being conducted at 4 °C. Cell lysates were clarified by centrifugation for 1 h at 200,000*g*, and proteins were bound to Flag M2--affinity gel (Sigma) and eluted with Flag peptide. For scattering analysis, full-length M6 was gel filtered using a Superdex 200 column in scattering buffer. For all constructs, absorbance at 280 nm in 6 M guanidinium chloride was used to determine the protein concentration.

Circular dichroism {#S11}
------------------

CD spectra were acquired using an Aviv 62DS instrument (Aviv Biomedical) with a 1-mm path-length cell in CD buffer. Spectra were taken at 10 °C, with data collected every 1 nm with a 20-s averaging time; results are the average of 3 repeat scans. Concentrations ranged from 1--17 μM. Melt data was collected every 1 °C with a 30-s averaging time and a 2-min equilibration. In all cases, the reverse melt showed at least 90% reversibility. The percent helical content was determined as described previously[@R41].

Multiple-angle light scattering {#S12}
-------------------------------

In solution, molecular weights were determined using a size-exclusion chromatography system coupled to a MALS detector. Protein concentrations were determined with an Optilab rEX refractive index detector, and scattering was detected with a Dawn 18 angle MALS light-scattering instrument (Wyatt Technology Corporation).

MALDI-TOF mass spectrometry {#S13}
---------------------------

Protein samples at \~10 μM in CD buffer were mixed in a 2:1 ratio with sinapinic acid and spotted onto a stainless steel MALDI plate. Analysis was conducted on a Voyager-DE RP (Applied Biosystems) instrument in positive linear mode.

Dynamic light scattering {#S14}
------------------------

Dynamic light scattering measurements were made using a DynaPro instrument (Protein Solutions) running Dynamics version 6 software. Samples at 1--10 mg ml^−1^ in scattering buffer were assayed at 25 °C with an acquisition interval of 10 s. Samples were spun at \~15,000*g* for 10 min immediately before analysis. Results were derived using a regularization fit and with PBS buffer settings.

Analytical gel filtration {#S15}
-------------------------

Proteins were concentrated to 10--300 μM and loaded onto a 25-ml Superdex 200 equilibrated in scattering buffer at 4 °C. The elution volume was determined from the average of at least three runs and converted to *R*~h~.

SAXS measurements {#S16}
-----------------

SAXS measurements were carried out at the XOR/BESSRC undulator beamline 12-ID of the Advanced Photon Source, using a sample-detector distance of 2 m and CCD detector readout (MAR USA). The data were collected using a custom-made sample cell[@R42] at an X-ray energy of 12 keV. Details of the beamline are as described previously[@R42]-[@R44].

Samples were centrifuged at 10,000*g* for 10 min before measurement, and three 0.5-s exposures were obtained. Data were image corrected, normalized by incident flux and circularly averaged. The three profiles for each condition were averaged to improve signal quality. Buffer profiles were collected using identical procedures and subtracted for background correction, and the data showed no signs of radiation damage, based on comparison of consecutive scattering profiles from the same sample (data not shown).

Small-angle X-ray scattering data analysis {#S17}
------------------------------------------

Scattering intensities as a function of the momentum transfer were obtained at different protein concentrations. The SAXS profiles for the MT-DT, PT-DT and full-length M6 constructs are superimposable after scaling by forward-scattering intensity, suggesting that there are no detectable aggregation or interparticle interference effects ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"} online). Radii of gyration were determined from Guinier analysis of the small momentum transfer scattering data[@R45] ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"} online). The radii of gyration obtained from Guinier analysis agree within experimental errors with the values from the real-space distribution function P(r) computed using the regularized transform method implemented in the program GNOM[@R46].

Small-angle X-ray scattering structure reconstructions {#S18}
------------------------------------------------------

The programs DAM-MIN[@R47] and GASBOR[@R48] were used to construct three-dimensional bead models that fit the scattering data ([Supplementary Fig. 6](#SD2){ref-type="supplementary-material"} online). Both programs use a simulated annealing procedure and a compactness criterion. We performed ten independent DAMMIN and GASBOR runs for each scattering profile, using default parameters, the 'slow' mode for DAMMIN, no symmetry assumptions (P1 symmetry) and the full recorded scattering profiles. The models resulting from independent runs were superimposed and compared using the program SUPCOMB[@R49] based on the normalized spatial discrepancy (NSD) criterion. Models with NSD values \<1 are considered similar. For all data presented in the main text, the ten independent repeat runs yielded models with pairwise NSD values \<1, indicating that the algorithms converged reproducibly to similar structures. The ten independent structures for each scattering profile were subsequently averaged, and 'filtered' consensus models were computed using the program DAMAVER with default settings[@R50]. Consensus models constructed with DAMMIN and GASBOR gave similar results. For visualization, the reconstructed bead models were converted to electron-density maps with the program Situs[@R51].

*In vitro* motility, landing and continuous movement assays {#S19}
-----------------------------------------------------------

Assays were conducted as described previously[@R32]. Briefly, motors were attached with monoclonal anti-GFP antibody (Chemicon MAB3580) to nitrocellulose-coated cover slips. Tetramethyl rhodamine iso-thiocyanate (TRITC) phalloidin-labeled actin was observed using a total internal reflection microscope[@R52]. Movies were scored for the number of filaments landing and moving more than 0.5 μm, the fraction of filaments running greater than their length and the velocity with which filaments moved.

Total internal reflection fluorescence motility assays {#S20}
------------------------------------------------------

Assays were conducted as described previously[@R52]. Briefly, actin biotinylated at 1 in approximately every 25 monomers was attached to a coverslip using steptavidin and nonspecifically absorbed biotinylated BSA. Motors were labeled at a 1:1 ratio with anti-GFP antibody conjugated with multiple Cy3 fluorophores to enhance signal were assayed at 80 μM ATP. Movies were collected on the microscope described in ref. [@R52] and analyzed using imageJ (National Institutes of Health).

Optical trap assays {#S21}
-------------------

Assays were conducted as described previously[@R3],[@R53] with a few exceptions, notably that trapping was done without feedback. Briefly, motors were attached with monoclonal anti-GFP antibody (Chemicon, MAB3580) to nitrocellulose-coated cover slips. Actin dumbbells were formed between two trapping beads and pulled taught. Positional data was collected at 10 kHz and trap stiffness ranged from 0.006--0.012 pN nm^−1^. Binding events were determined by eye using a drop in the positional variance of the beads and the bead-to-bead . Transitions between processive steps were also scored by eye.

Supplementary Material {#S22}
======================

###### 

Note: Supplementary information is available on the Nature Structural *&* Molecular Biology website.
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![M6 tail domains and experimental constructs. The tail domains of M6 are indicated in the context of the full-length protein, with the position of the first residue of each domain in the human sequence annotated. The calmodulin binding domains are the heretofore known elements of the lever arm (LA); the end of the IQ helix is residue 835. Sequences from the MT from four species are presented to show the repeating-charge pattern, which switches approximately every four residues. The *E. coli* -- expressed tail fragments are shown along with the construct name. The control M6 dimer, the MT locked mutant and the PT mutant constructs were modified by insertion of a GCN4 segment (black regions) to ensure dimerization at the low concentrations used for single-molecule analyses and by replacing the cargo binding domain (CBD) with YFP to provide a specific surface-attachment point via a YFP monoclonal antibody. The location of the randomized PT is gray.](nihms53111f1){#F1}

![CD spectra for the PT and MT-DT domains. (**a**) A typical CD spectrum of the PT showing the characteristic double minima of an α-helical protein. Inset, the thermal melt of the PT showing the cooperative melt typical of a folded protein. (**b**) CD spectra of the MT-DT as a monomer (red) or as an artificial dimer held together by a C-terminal disulfide bridge (blue). Inset, thermal melt curves showing that both constructs have a broad thermal unfolding transition as expected for a single α-helix. The similarity of the spectra and melt curves of the monomer and dimer indicates that no structural changes occur when the MT-DT is placed in conditions mimicking high concentrations. This indicates an inability of the MT-DT to dimerize.](nihms53111f2){#F2}

![SAXS envelope reconstructions of tail domains. (**a**) A model of the MT-DT structure with the MT structure (green) derived from the single α-helix prediction and the DT structure (orange) from a Rosetta prediction[@R28]. The model was constructed by aligning the peptide backbone manually to the consensus best GASBOR reconstruction and then docking the model into the filtered GASBOR reconstruction envelope using the Situs software package[@R51]. (**b**) A model of the PT-DT structure was constructed by adding a Rosetta prediction for the PT structure (blue) to the N terminus of the MT-DT model in **a**. This model was docked as above into the filtered GASBOR reconstruction. Note that even though the number of residues has increased from 129 to 201 (56%), the envelope is only \~3 nm longer, indicating a compact PT. Inset, the structure of a segment of the highly charged MT (residues 935--955), with the side chain atoms color coded by charge, revealing bands of charge circling the helix and providing stabilizing i to i+4 charge-charge interactions.](nihms53111f3){#F3}

![Motility assays for the MT locked mutant compared to control M6 dimer. (**a**) Plots of log landing rate versus log motor density with lines depicting the processive model and the nonprocessive model superimposed on the data. The control M6 dimer data match the processive model (number of motors for attachment = 1.0), and the MT locked data more closely match the nonprocessive model (number of motors for attachment = 2.0). (**b**) Plots of the probability of a filament moving further than its length versus log motor density. As described for **a**, models for processive and nonprocessive movement were superimposed over the data, with the control M6 dimer being in better agreement with the one-motor model (*r*^2^ processive model = 0.98, *r*^2^ nonprocessive model = 0.95) and the MT locked mutant being in better agreement with the two-motor model (*r*^2^ processive model = 0.93, *r*^2^ nonprocessive model = 0.97). (**c**) Histogram of measured nonprocessive displacements for the MT locked mutant in a dual-beam optical trap assay. The mean displacement is indicated and represents the length of the power stroke of the motor. All error bars are standard errors.](nihms53111f4){#F4}

![SAXS envelope and models for full-length myosin VI. (**a**) A model of an extended full-length M6 containing the published post-stroke crystal structure of the catalytic domain[@R5] with the calmodulin-bound unique insert and IQ regions (purple), the PT-DT model from [Figure 3b](#F3){ref-type="fig"} and the Rosetta prediction of the CBD (magenta) docked into the corresponding SAXS envelope. With the head aligned to one end of the reconstruction and the PT fused to the IQ such that it extends the lever arm in the same conformation as in [Figure 6](#F6){ref-type="fig"}, the rest of the tail lies well outside the calculated scattering envelope. (**b**) A model of an alternate compact state for monomeric M6, with the CBD folded back onto the lever arm calmodulins, docked into the same SAXS envelope as in **a**.](nihms53111f5){#F5}

![A scale model of a M6 dimer moving along an actin filament. The F-actin--docked myosin model is based on that proposed by Holmes *et al.*[@R54] Monomers corresponding to the two protofilaments are colored in light and dark gray, respectively, to emphasize the pseudorepeat at 36 nm. Using a structural alignment in PyMOL (<http://pymol.sourceforge.net>), the post-stroke structure of the M6 head (PDB 2BKI[@R5]) was docked onto the filament. The prestroke structure (PDB 2V26[@R19]) was also docked onto the actin filament 13 monomers removed from the post-stroke head. These structures along with the associated light chains are shown in purple. The tail model presented in [Figure 3b](#F3){ref-type="fig"}, with the same color scheme, has been fused to the end of the IQ domains such that the PT projects along the same vector as the IQ helix (cyan) and then rotates around the Gly839 to remove steric clashes. This represents an orientation where the PT maximally contributes to the M6 stroke, which is one of many potential angles at which it meets the IQ domain. The cargo binding domains are shown in close association, as their dimerization suggests. The SAXS envelopes were then superimposed on the model to place the data in context of a working motor using Chimera[@R55]. This model shows that the proposed roles for the tail domains are clearly compatible with a 36-nm processive step for a M6 dimer.](nihms53111f6){#F6}

###### 

Molecular weights and dimensions of various myosin VI constructs

  Construct                           Predicted MW (kDa)                     MALDI[a](#TFN2){ref-type="table-fn"} (kDa)   MALS (kDa)    Maximum concentration in MALS (μM)   Oligomerization state   *R*~h~ (nm)                                                                          *R*~g~[b](#TFN3){ref-type="table-fn"} (nm)
  ----------------------------------- -------------------------------------- -------------------------------------------- ------------- ------------------------------------ ----------------------- ------------------------------------------------------------------------------------ --------------------------------------------
  PT[c](#TFN4){ref-type="table-fn"}   9.0                                    9.0                                          16.3 ± 0.1    167                                  Dimer                   1.6 ± 0.1[d](#TFN5){ref-type="table-fn"}, 2.2 ± 0.1[d](#TFN5){ref-type="table-fn"}   2.2 ± 0.2
  PT to DT                            22.9                                   23.2                                         23.3 ± 0.1    45.6                                 Monomer                 4.1 (11.6%)[e](#TFN6){ref-type="table-fn"}                                           4.4 ± 0.2
  MT to DT                            15.0                                   15.2                                         17.1 ± 0.3    18.8                                 Monomer                 3.6 (12%)[e](#TFN6){ref-type="table-fn"}                                             4.3 ± 0.2
  PT to CBD                           53.5                                   52.9                                         110.8 ± 4.4   0.4                                  Dimer                   5.7 (13.7%)[e](#TFN6){ref-type="table-fn"}                                           ND
  Full length                         181.7[f](#TFN7){ref-type="table-fn"}   ND                                           202.6 ± 4.0   1.0                                  Monomer                 5.3 ± 0.3[d](#TFN5){ref-type="table-fn"}                                             4.6 ± 0.2

Standard errors are shown, unless otherwise indicated. ND, not determined.

MALDI MS polypeptide chain molecular weight.

Radii of gyration from Guinier analysis from SAXS data.

It should be noted that, at the high concentration used in these studies, PT alone dimerizes, presumably artificially, with a weak *K*~d~ of \~150 μM ([Supplementary Fig. 3c](#SD2){ref-type="supplementary-material"}); when purified as PT-DT, PT remains monomeric even at these high concentrations. The *R*~h~ for both monomer and dimer can be measured by gel filtration and are presented, but only the dimer form is seen in MALS and SAXS analyses due to the high concentration of protein used in those measurements ([Supplementary Fig. 3a,b](#SD2){ref-type="supplementary-material"}).

By gel filtration ± s.d.

By dynamic light scattering with polydispersity in parentheses.

Combined molecular weight of one heavy chain and two calmodulin light chains.
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